Retatrutide Pen (Alluvi Healthcare)

Retatrutide is a novel, triple agonist peptide that targets the GLP-1, GIP, and glucagon receptors—designed to support metabolic balance and weight management.

Retatrutide Pen (Alluvi Healthcare) is supplied as a high-purity research compound for qualified laboratory and analytical applications. Each batch is handled through consistency-focused production and quality-control workflows.

Researchers should follow appropriate laboratory handling, storage, and safety protocols. Review the batch documentation before beginning any analytical procedure.